首页> 外国专利> MOLLUSCAN NEUROPEPTIDE HAVING FR STRUCTURE AT N-TERMINAL

MOLLUSCAN NEUROPEPTIDE HAVING FR STRUCTURE AT N-TERMINAL

机译:在N末端具有FR结构的神经肽

摘要

PURPOSE: To obtain a new neuropeptide capable of providing a new means for pharmacological research. ;CONSTITUTION: The objective new neuropeptide is expressed by the following amino acid sequence formulas (a) and (b): (a) H-Phe-Arg-Thr-Phe-X-Y-OH and (b) H-Phe-Arg-Pro-Leu-OH (amino acid residue is noted by the three letter notation defined by the IUPAC and IUB; X denotes single bond, Glu residue or Gln residue; Y denotes single bond or Lys residue). Although this neuropeptide is a neuropeptide capable of suppressing strong contraction of an anterior byssus retractor muscle in Mytilus edulis by electrical stimulation and is obtained from a ganglion of Helix pomatia produced in Hungary by combining high- performance liquid chromatography, it can be synthesized by a commercially available automatic peptide synthesizer. This neuropeptide is not only useful as the neuropeptide but also capable of providing a new approach to medicines and agricultural chemicals, etc.;COPYRIGHT: (C)1994,JPO&Japio
机译:目的:获得一种能够为药理研究提供新手段的新神经肽。 ;组成:目标新神经肽由以下氨基酸序列公式(a)和(b)表示:(a)H-Phe-Arg-Thr-Phe-XY-OH和(b)H-Phe-Arg- Pro-Leu-OH(氨基酸残基由IUPAC和IUB定义的三个字母表示; X表示单键,Glu残基或Gln残基; Y表示单键或Lys残基)。尽管该神经肽是能够通过电刺激来抑制可食性Mytilus eduss中前屈肌牵肌的强烈收缩的神经肽,并且是通过结合高效液相色谱法从匈牙利生产的Helix pomatia的神经节中获得的,但是它可以通过商业途径合成可用的自动肽合成仪。这种神经肽不仅可用作神经肽,而且还可以为药物和农用化学药品等提供新的方法。版权所有:(C)1994,日本特许厅

著录项

  • 公开/公告号JPH0673094A

    专利类型

  • 公开/公告日1994-03-15

    原文格式PDF

  • 申请/专利权人 SUNTORY LTD;

    申请/专利号JP19920269036

  • 申请日1992-08-27

  • 分类号C07K7/06;C07K5/10;

  • 国家 JP

  • 入库时间 2022-08-22 04:51:00

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号